StonvexLoading…
StonvexStonvexStonvexCore line items from XYL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $9.04B | $8.56B | $7.36B | $5.52B |
Operating Income | $1.22B | $1.01B | $652.00M | $622.00M |
Net Income | $957.00M | $890.00M | $609.00M | $355.00M |
EPS (Diluted) | $3.92 | $3.65 | $2.79 | $1.96 |
Total Assets | $17.63B | $16.49B | $16.11B | $7.95B |
Total Liabilities | $5.88B | $5.61B | $5.94B | $4.45B |
Cash & Equivalents | $1.48B | $1.12B | $1.02B | $944.00M |
Free Cash Flow OCF − CapEx | $910.00M | $942.00M | $566.00M | $388.00M |
Shares Outstanding | 243.58M | 242.99M | 241.50M | 180.25M |